Global Total Artificial Heart Market Growth 2023-2029

Global Total Artificial Heart Market Growth 2023-2029

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
LPI (LP Information)' newest research report, the “Total Artificial Heart Industry Forecast” looks at past sales and reviews total world Total Artificial Heart sales in 2022, providing a comprehensive analysis by region and market sector of projected Total Artificial Heart sales for 2023 through 2029. With Total Artificial Heart sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Total Artificial Heart industry.
This Insight Report provides a comprehensive analysis of the global Total Artificial Heart landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Total Artificial Heart portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Total Artificial Heart market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Total Artificial Heart and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Total Artificial Heart.
The global Total Artificial Heart market size is projected to grow from US$ 38 million in 2022 to US$ 158 million in 2029; it is expected to grow at a CAGR of 158 from 2023 to 2029.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Total Artificial Heart market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
SynCardia
Others
Segmentation by application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Total Artificial Heart market?
What factors are driving Total Artificial Heart market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Total Artificial Heart market opportunities vary by end market size?
How does Total Artificial Heart break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.